Wikidata

(Q64608501)

English

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Phase 2, Open Label Study to Evaluate The Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) Tablet for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection (English)
0 references
country
Austria
0 references
France
0 references
Germany
0 references
Italy
0 references
start time
14 October 2014
0 references
end time
24 March 2016
0 references
number of participants
114
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64608501&oldid=2235580524"